Left ventricular cavity obliteration: Mechanism of the intracavitary gradient and differentiation from hypertrophic

Charles Pollick1, Hezzy Shmueli1, Nicolas Maalouf1

  • 1Smidt Heart Institute, Cedars Sinai Medical Center, Los Angeles, California, USA.

Insights

The intracavitary gradient (ICG) in left ventricular cavity obliteration (LVCO) is linked to the extent and duration of LVCO. Differentiating ICG spectral profiles helps distinguish LVCO from hypertrophic obstructive cardiomyopathy (HOCM) and aortic stenosis (AS).

Area of Science:

  • Cardiology
  • Cardiovascular Imaging
  • Hemodynamics

Background:

  • The cause of pressure gradients in hypertrophic obstructive cardiomyopathy (HOCM) is debated, with both left ventricular cavity obliteration (LVCO) and systolic anterior motion (SAM) of the mitral valve implicated.
  • While distinct in origin, LVCO and SAM-associated gradients share characteristics like a

Purpose of the Study:

  • To clarify the cause and characteristics of intracavitary gradients (ICG) in patients with LVCO without HOCM.
  • To differentiate ICG spectral profiles in LVCO from those in HOCM and severe aortic stenosis (AS).

Main Methods:

  • Assessed the extent and duration of LVCO in patients without HOCM.
  • Compared spectral profiles of ICG in LVCO patients with those of HOCM and severe AS patients.

Main Results:

  • Higher ICG correlates with greater LV wall apposition extent and duration, and smaller left ventricular cavity size.
  • Peak/mean gradient ratios differentiate spectral profiles: ≤2 for AS, 2-3 for HOCM, and >3 for LVCO (>90% accuracy).
  • Most LVCO patients without HOCM or severe LVH have ICG < 36 mm Hg.

Conclusions:

  • The magnitude of ICG is quantitatively associated with LVCO extent and duration.
  • Spectral profiles, specifically the peak/mean gradient ratio, effectively differentiate severe AS, HOCM, and LVCO.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
277
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
577
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
256
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
216
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.1K
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
274